← All companies
Amylyx Pharmaceuticals, Inc.
AMLX - CIK 0001658551
Market cap$1.50 B
Rank#2318
SEC filings403
The table below shows Amylyx Pharmaceuticals, Inc.'s balance sheet line items across its last 4 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash & equivalents | $226.65M | $77.39M | $170.20M | $62.53M |
| Short-term investments | - | - | $201.16M | $284.42M |
| Receivables | $88.00K | $447.00K | $40.05M | $15.31M |
| Inventory | - | $38.32M | $38.32M | $9.77M |
| Total current assets | $323.67M | $189.43M | $464.67M | $382.13M |
| Property, plant & equipment | $310.00K | $961.00K | $2.69M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.